Search results
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
Zacks via Yahoo Finance Canada· 9 hours agoKymera Therapeutics, Inc. KYMR announced that partner Sanofi SNY intends to rapidly expand the...
Kymera Therapeutics soars as Sanofi expands phase 2 trials
Investing.com via Yahoo Finance Canada· 7 hours agoInvesting.com - Kymera Therapeutics Inc , (NASDAQ:KYMR) a clinical-stage biopharmaceutical firm specializing in the development of novel small molecule medicines using targeted protein degradation ...
These Stocks Moved the Most Today: Tesla, Corning, Nvidia, BP, Albemarle, Helen of Troy, Kymera, and...
Barrons.com· 3 hours agoTesla shares are on track for their 10th-straight gain, Corning extends gains, and BP expects to...
FTC Chair Khan slams PBMs for higher drug prices in an interim report on the industry
Yahoo Finance· 5 hours agoThe FTC released a much-anticipated interim report without taking any action. It comes as the Biden...
Assured Guaranty, Kymera rise; BP, Helen of Troy fall, Tuesday, 7/9/2024
Associated Press via Yahoo Finance Canada· 7 hours agoThe technology company announced plans for a sale of up to $125 million in stock. Kymera Therapeutics Inc., up $7.48 to $39.44. The biopharmaceutical company's partner, Sanofi
Bénéteau And Two Other Leading Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance Canada· 17 hours agoAmidst a backdrop of political shifts and economic uncertainties across Europe, France's market has...
